Clinical tests of huatan Huoxue Jiangqi prescription in treatment of chronic obstructive pulmonary disease
10.3969/j.issn.1006-5725.2016.07.044
- VernacularTitle:化痰活血降气方治疗慢性阻塞性肺疾病的临床试验
- Author:
Nian ZHANG
;
Renyi YIN
;
Wensheng YUAN
;
Jiemin SUN
;
Qian XIA
;
Ying HUANG
- Publication Type:Journal Article
- Keywords:
COPD;
Huatan Huoxue Jiangqi prescription;
Fibrinogen;
C-reactive protein
- From:
The Journal of Practical Medicine
2016;32(7):1176-1179
- CountryChina
- Language:Chinese
-
Abstract:
Objective To investigate the Huatan Huoxue Jiangqi prescription in treating AECOPD clinical curative effect. Methods 123 patients with AECOPD were randomly divided into the treatment group and the control group. The two groups were treated with western medicine, and the treatment group added with Chinese herbal medicine treatment with Huatan Huoxue Jiangqi prescription. The syndrome effect, clinical symptom score, CAT score, mMRC classification, lung function, the serum FIB and CRP levels were obtained to evaluate the efficacy of the two groups before and after treatment. Results The syndrome effect of the treatment group was significantly better than that of the control group. Compared with the control group, there was significant difference between traditional Chinese medicine syndrome score, CAT score (P < 0.05); Lung function (including FEV1, FEV1%, FEV1/FVC) was significantly improved in the treatment group after treatment (P < 0.05). The serum FIB and CRP levels decreased significantly in the treatment group compared with the control group (P < 0.05). Conclusion Huatan Huoxue Jiangqi prescription has reliable effets on treating AECOPD.
